Paid Clinical Trials Shreveport

Discover 161 paid clinical trials in Shreveport, Louisiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 161

Observational StudyOptilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters

Recruiting

Sponsor:

Urotronic Inc.

Location:

Shreveport LA, Little Rock AR, Dallas TX, Tampa FLshow 5 more

Code:

NCT05383274

Conditions

Urethral Stricture

Eligibility Criteria

Sex: Male

Age: 22 - 65

Healthy Volunteers: Not accepted

Interventions

Optilume Urethral DCB

Budesonide, Glycopyrronium, FormoterolA Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Shreveport LA, Monroe LA, Paris TX, Forney TXshow 196 more

Code:

NCT06283966

Conditions

COPD (Chronic Obstructive Pulmonary Disease)

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

BGF MDI 320/14.4/9.6 μg

GFF MDI 14.4/9.6 μg

BHV-7000Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Recruiting

PHASE2

PHASE3

Sponsor:

Biohaven Therapeutics Ltd.

Location:

Shreveport LA, Baton Rouge LA, Houston TX, Memphis TNshow 27 more

Code:

NCT06309966

Conditions

Focal Epilepsy

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

BHV-7000

Placebo

Sacituzumab Tirumotecan & PembrolizumabSacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Shreveport LA, Tyler TX, Monroe LA, Dallas TXshow 38 more

Code:

NCT06393374

Conditions

Triple-Negative Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Sacituzumab tirumotecan

Capecitabine

Steroids & TKIsTesting the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Shreveport LA, Dallas TX, Fort Smith AR, Houston TXshow 142 more

Code:

NCT04530565

Conditions

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Blinatumomab

Bone Marrow Aspiration and Biopsy

Cyclophosphamide

Cytarabine

BupropionBupropion to Reduce Cancer Related Fatigue in Cancer Survivors

Recruiting

PHASE3

Sponsor:

University of Rochester NCORP Research Base

Location:

Shreveport LA, Fort Smith AR, Baton Rouge LA, Covington LAshow 290 more

Code:

NCT03996265

Conditions

Be Diagnosed With Cancer and Have Completed Systemic Therapy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bupropion Hydrochloride Controlled-release

Placebo Administration

Quality-of-Life Assessment

Questionnaire Administration

OSTEOAMPOSTEOAMP Lumbar Fusion Intra-Patient Controlled Study

Recruiting

Sponsor:

Bioventus LLC

Location:

Shreveport LA, Austin TX, Wichita KS, Paducah KYshow 5 more

Code:

NCT05405374

Conditions

Lumbar Spine Disease

Lumbar Spondylolisthesis

Lumbar Spine Instability

Lumbar Spondylosis

Degenerative Disc Disease

Eligibility Criteria

Sex: All

Age: 21 - 70+

Healthy Volunteers: Not accepted

Interventions

OSTEOAMP

Infuse

SurvodutideLIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Recruiting

PHASE3

Sponsor:

Boehringer Ingelheim

Location:

Shreveport LA, Monroe LA, Garland TX, Dallas TXshow 69 more

Code:

NCT06632457

Conditions

Metabolic Dysfunction Associated Steatohepatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Survodutide

Placebo matching survodutide

CrizotinibCrizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

Recruiting

PHASE3

Sponsor:

ECOG-ACRIN Cancer Research Group

Location:

Shreveport LA, Monroe LA, Alexandria LA, Hot Springs ARshow 977 more

Code:

NCT02201992

Conditions

ALK Gene Rearrangement

ALK Gene Translocation

ALK Positive

Stage IB Non-Small Cell Lung Carcinoma AJCC v7

Stage II Non-Small Cell Lung Cancer AJCC v7

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Clinical Observation

Crizotinib

Laboratory Biomarker Analysis

Ruxolitinib CreamA Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

Recruiting

PHASE3

Sponsor:

Incyte Corporation

Location:

Longview TX, Hot Springs AR, Dallas TX, Grapevine TXshow 68 more

Code:

NCT06548360

Conditions

NonSegmental Vitiligo

Eligibility Criteria

Sex: All

Age: 2 - 11

Healthy Volunteers: Not accepted

Interventions

Ruxolitinib Cream

Vehicle Cream